XTRA:EVTLife Sciences
Evotec (XTRA:EVT) Launches J.TRAIN, Is The Stock Trading At A Discount?
Evotec (XTRA:EVT) is back in focus after Just – Evotec Biologics rolled out J.TRAIN, a turnkey platform that lets biopharmaceutical companies install its continuous biologics manufacturing technology directly inside their own facilities.
See our latest analysis for Evotec.
While J.TRAIN is drawing attention to Evotec's biologics capabilities, the stock price tells a mixed story, with a 1-day share price return of 1.94% and a 90-day share price return of 13.15% set against a 1-year total...